Kenneth Wang is listed as a director on 1 SEC Form D filing by 1 issuer in May 2012: BLOOD CELL STORAGE INC (Seattle, WA — biotechnology — 2012; $2.38M reported sold to 21 investors).
What this means One deal on file with the SEC, filed May 2012. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Donald Gher (1 shared filing), Geoff Holmes (1 shared filing), Justin Foley (1 shared filing) and Russell Aldrich (1 shared filing).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Kenneth. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 1 court case matching the name listed in Key records below.
What this means 1 record came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 1 public filing for Kenneth Wang and found 6 differences: Kenneth Wang appears on 1 deal that stopped filing before reaching its target; No amendment in the last 12 months on an offering that may still be open; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.